Ketorolac Tromethamine Injection 60 mg Per 2 mL Vials (Rx)


Ketorolac tromethamine is a potent nonsteroidal anti-inflammatory drug (NSAID) used as an injectable painkiller. It is the generic form of the prescription analgesic Toradol. Each 2 mL vial contains 60 mg (30 mg/mL) of ketorolac tromethamine for injection. This injectable form is typically given by healthcare providers in a hospital or clinic (intramuscular) for acute pain control.
Ketorolac injection is indicated for short-term relief of moderately severe pain (often postoperative or injury-related) in adults and adolescents 17 years or older . It is not intended for mild pain, chronic conditions, or use beyond 5 days because of its risk profile. In practice, patients receive their first doses by injection, and in some cases may switch to oral ketorolac or other therapies once they can take pills.
Dosage:
The injection is given by a healthcare professional, either into a muscle (IM) or into a vein (IV). Dosing is generally every 4–6 hours as needed for pain, with typical single doses of 15 mg IV or 30 mg IM (accomplished by drawing from the 60 mg/2 mL vial). A maximum of 5 days total therapy is strictly observed; ketorolac is not used continuously beyond five days or for chronic pain. (After injection therapy, doctors may switch appropriate patients to oral NSAIDs.)
Mechanism of action: Ketorolac works like other NSAIDs by blocking the cyclooxygenase (COX) enzymes, which are needed to produce prostaglandins and other mediators of pain, fever, and inflammation. By inhibiting COX, ketorolac reduces prostaglandin synthesis, thereby diminishing pain and inflammation. It is a very effective non-opioid analgesic for acute pain; in fact, it is often used to supplement or reduce opioid requirements after surgery
Ketorolac Tromethamine is a prescription-only NSAID designed for short-term management of severe acute pain that requires injectable administration. It inhibits prostaglandin synthesis, significantly reducing inflammation, swelling, and pain without the risks associated with addictive opioids. Frequently used for surgical pain, orthopedic pain, dental pain, renal colic, and musculoskeletal pain, it is trusted by medical professionals worldwide.
Sagent Pharmaceuticals is a trusted leader in providing high-quality injectable medications for hospitals, clinics, and healthcare professionals. Every batch is manufactured to the strictest quality standards, ensuring efficacy and patient safety with each use.
Details and Features:
Dosage Form: 60 mg per 2 mL vial
Packaging: 25 vials per pack
Administration Route: Intended for intravenous (IV) or intramuscular (IM) injection
Use: Short-term management of moderate to severe acute pain, typically used for no more than five days
Non-Opioid Analgesic: Provides pain relief without the potential for opioid dependence
Warnings:
Side Effects:
Common side effects of ketorolac injection are related to its NSAID action. These include gastrointestinal upset (stomach pain, nausea, indigestion) and headache. Mild dizziness or drowsiness can also occur. Because ketorolac inhibits prostaglandins, it can irritate the stomach lining; some patients may experience indigestion or mild GI discomfort. Injection-site reactions (pain or swelling) may happen but are usually minor.Serious warnings and precautions: Ketorolac carries significant warnings. Like other NSAIDs, it can cause severe gastrointestinal bleeding or ulcers and kidney damage, especially with high doses or prolonged use. It also increases the risk of cardiovascular events; patients on NSAIDs (including ketorolac) have a higher risk of heart attack or stroke than those not on NSAIDs. Because of these risks, ketorolac is limited to very short courses and only for appropriate patients. It is contraindicated (should not be used) in patients with a known allergy to ketorolac or other NSAIDs, in those with active peptic ulcer/bleeding, or in people with advanced kidney disease. It should not be used around the time of major surgery (e.g. coronary bypass) or after 20 weeks of pregnancy (risking fetal harm). Patients receiving ketorolac are monitored carefully – for example, blood pressure and kidney function – and therapy is stopped immediately if serious adverse effects (like bleeding, liver problems, or signs of heart issues) occur.
Common side effects may include:
Ketorolac Tromethamine Injection should be administered under medical supervision with careful monitoring of patient condition and response to therapy. It is critical to adhere to recommended dosing and duration guidelines to minimize the risk of adverse effects. Regular evaluations ensure the treatment remains necessary and beneficial.
Ketorolac tromethamine is a potent nonsteroidal anti-inflammatory drug (NSAID) used as an injectable painkiller. It is the generic form of the prescription analgesic Toradol. Each 2 mL vial contains 60 mg (30 mg/mL) of ketorolac tromethamine for injection. This injectable form is typically given by healthcare providers in a hospital or clinic (intramuscular) for acute pain control.
Ketorolac injection is indicated for short-term relief of moderately severe pain (often postoperative or injury-related) in adults and adolescents 17 years or older . It is not intended for mild pain, chronic conditions, or use beyond 5 days because of its risk profile. In practice, patients receive their first doses by injection, and in some cases may switch to oral ketorolac or other therapies once they can take pills.
Dosage:
The injection is given by a healthcare professional, either into a muscle (IM) or into a vein (IV). Dosing is generally every 4–6 hours as needed for pain, with typical single doses of 15 mg IV or 30 mg IM (accomplished by drawing from the 60 mg/2 mL vial). A maximum of 5 days total therapy is strictly observed; ketorolac is not used continuously beyond five days or for chronic pain. (After injection therapy, doctors may switch appropriate patients to oral NSAIDs.)
Mechanism of action: Ketorolac works like other NSAIDs by blocking the cyclooxygenase (COX) enzymes, which are needed to produce prostaglandins and other mediators of pain, fever, and inflammation. By inhibiting COX, ketorolac reduces prostaglandin synthesis, thereby diminishing pain and inflammation. It is a very effective non-opioid analgesic for acute pain; in fact, it is often used to supplement or reduce opioid requirements after surgery
Ketorolac Tromethamine is a prescription-only NSAID designed for short-term management of severe acute pain that requires injectable administration. It inhibits prostaglandin synthesis, significantly reducing inflammation, swelling, and pain without the risks associated with addictive opioids. Frequently used for surgical pain, orthopedic pain, dental pain, renal colic, and musculoskeletal pain, it is trusted by medical professionals worldwide.
Sagent Pharmaceuticals is a trusted leader in providing high-quality injectable medications for hospitals, clinics, and healthcare professionals. Every batch is manufactured to the strictest quality standards, ensuring efficacy and patient safety with each use.
Details and Features:
Dosage Form: 60 mg per 2 mL vial
Packaging: 25 vials per pack
Administration Route: Intended for intravenous (IV) or intramuscular (IM) injection
Use: Short-term management of moderate to severe acute pain, typically used for no more than five days
Non-Opioid Analgesic: Provides pain relief without the potential for opioid dependence
Warnings:
Side Effects:
Common side effects of ketorolac injection are related to its NSAID action. These include gastrointestinal upset (stomach pain, nausea, indigestion) and headache. Mild dizziness or drowsiness can also occur. Because ketorolac inhibits prostaglandins, it can irritate the stomach lining; some patients may experience indigestion or mild GI discomfort. Injection-site reactions (pain or swelling) may happen but are usually minor.Serious warnings and precautions: Ketorolac carries significant warnings. Like other NSAIDs, it can cause severe gastrointestinal bleeding or ulcers and kidney damage, especially with high doses or prolonged use. It also increases the risk of cardiovascular events; patients on NSAIDs (including ketorolac) have a higher risk of heart attack or stroke than those not on NSAIDs. Because of these risks, ketorolac is limited to very short courses and only for appropriate patients. It is contraindicated (should not be used) in patients with a known allergy to ketorolac or other NSAIDs, in those with active peptic ulcer/bleeding, or in people with advanced kidney disease. It should not be used around the time of major surgery (e.g. coronary bypass) or after 20 weeks of pregnancy (risking fetal harm). Patients receiving ketorolac are monitored carefully – for example, blood pressure and kidney function – and therapy is stopped immediately if serious adverse effects (like bleeding, liver problems, or signs of heart issues) occur.
Common side effects may include:
Ketorolac Tromethamine Injection should be administered under medical supervision with careful monitoring of patient condition and response to therapy. It is critical to adhere to recommended dosing and duration guidelines to minimize the risk of adverse effects. Regular evaluations ensure the treatment remains necessary and beneficial.
You need an account to add products to your wishlist. Log in or create an account to start saving your favorites.